Title : Repurposing FDA Drug Compounds against Breast Cancer by Targeting EGFR/HER2.

Pub. Date : 2021 Aug 12

PMID : 34451888






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In this study, we first identified FDA-approved compounds with similar structures in the DrugBank to lapatinib and gefitinib, two known inhibitors of EGFR and HER2. Lapatinib epidermal growth factor receptor Homo sapiens